A rare case of asymptomatic Paget’s disease of the skull in a 60-year-old Asian female
Background and aim: Paget’s disease of the bone (PDB) refers to a chronic cumulative disorder characterized by enhanced osteoclastic function followed by a secondary surge in osteoblastic activity. The condition can manifest as a polyostotic or monostotic bone disease with most patients having an asymptomatic presentation, although some may complain of pain localized to the affected bone while others express symptoms of nerve compression. A Pagetic bone is predisposed to develop pathological fractures, bony deformities, and a rare yet detrimental transformation into osteosarcoma. Detection is often accidental when performing radiographic tests for other indications or when elevated blood levels of alkaline phosphatase (ALP) are detected. Treatment with third-generation bisphosphonates is helpful in preventing further bone resorption and additionally, reduces bony pains that are believed to be caused by excessive metabolic activity. Here we present a case of a middle-aged asymptomatic female with elevated serum ALP levels up to 1537 IU/L (reference range 40-150 U/L) during her pre-operative evaluation for elective cholecystectomy. 99mTc-methylene diphosphonate (MDP) bone scintigraphy revealed diffuse uptake in the skull and hence was diagnosed as a case of isolated Paget’s disease of the skull.
Relevance for Patients: The rarity of this disease in Southeast-Asians, its uncontrived detection, and the isolated skull involvement, impart high clinical relevance on this case. Early detection and management of this disease can help prevent development of life-threatening complications in affected patients, hence decreasing the morbidity.
[1] Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH. Bisphosphonates for Paget’s Disease of Bone in Adults. Cochrane Database Syst Rev 2017;12:CD004956.
[2] Rianon NJ, Des Bordes JK. Paget Disease of Bone for Primary Care. Am Fam Physician 2020;102:224-8.
[3] Theodorou DJ, Theodorou SJ, Kakitsubata Y. Imaging of Paget Disease of Bone and Its Musculoskeletal Complications: Review. AJR Am J Roentgenol 2011;196:S64-75.
[4] Caicedo AI, Escobar VE, Coy Urrea VA, Charry JS, Loaiza JH. Sporadic Paget’s Disease of the Bone. Case Series and Literature Review. Rev Colomb Reumatol (English Ed) 2020;27:103-11.
[5] Karunakaran K, Murugesan P, Rajeshwar G, Babu S. Paget’s Disease of the Mandible. J Oral Maxillofac Pathol 2012;16:107-9.
[6] Bone HG. Nonmalignant Complications of Paget’s Disease. J Bone Miner Res 2006;21:P64-8.
[7] Shankar YU, Misra SR, Vineet DA, Baskaran P. Paget Disease of Bone: A Classic Case Report. Contemp Clin Dent 2013;4:227-30.
[8] Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, et al. Lyles, Paget’s Disease of Bone: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab2014;99:4408-22.
[9] Aransiola CO, Ipadeola A. Asymptomatic Paget’s Disease of Bone in a 62-Year-Old Nigerian Man: Three Years PostAlendronate Therapy. Endocrinol Diabetes Metab Case Rep 2016;2016:160005. Publisher’s note AccScience Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
[10] Michou L, Brown JP. Emerging Strategies and Therapies for Treatment of Paget’s Disease of Bone. Drug Des Devel Ther 2011;5:225-39.
[11] Durgia H, Sahoo J, Kamalanathan S, Palui R, Kumar R, Halanaik D, et al. Response to Zoledronic Acid in Patients with Active Paget’s Disease of Bone: A Retrospective Study. Indian J Endocrinol Metab 2019;23:117-21.
[12] De Castro GR, Buss ZD, Rosa JS, Facchin BM, Fröde TS. Evaluation of Bone Metabolism Biomarkers in Paget’s Disease of Bone. Cureus 2019;11:e4791.